20/20 Biolabs
AIDX
16 hedge funds and large institutions have $236K invested in 20/20 Biolabs in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
7% more funds holding
Funds holding: 15 → 16 (+1)
0.18% less ownership
Funds ownership: 4.41% → 4.24% (-0.18%)
0% less capital inflows, than outflows
Capital inflows: $43.8K | Capital outflows: $44K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$21K |
| 2 |
XTX Topco
George Town,
Cayman Islands
|
+$16.9K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.76K |
| 4 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$2.58K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$298 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRT Financial
New York
|
-$38.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.5K |
| 3 |
Toth Financial Advisory
Leesburg,
Virginia
|
-$55 |
AIDX Hedge Fund Activity: Q3 2026 in Review
16 of the 8,207 institutional investors tracked by Wall St. Rank reported a position in 20/20 Biolabs (AIDX) for Q3 2026, worth a combined $236K — down 21% from $297K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new AIDX positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $21K. The largest seller was HRT Financial, cutting an estimated $38.4K.
- 16 institutional investors held 20/20 Biolabs (AIDX) as of Q3 2026, up from 15 in Q2 2026.
- Funds reported $236K of 20/20 Biolabs stock for Q3 2026, down 21% quarter-over-quarter.
- 3 funds opened new 20/20 Biolabs positions in Q3 2026 and 2 closed out, a net change of +1 holder.
- The largest 20/20 Biolabs buyer in Q3 2026 was Citadel Advisors, an estimated $21K added.
- The largest 20/20 Biolabs seller in Q3 2026 was HRT Financial, an estimated $38.4K sold.
Based on aggregated 13F filings for Q3 2026.